• (18)F-fluoro-ethyl-tyrosine PET co-registered with MRI in patients with persisting acromegaly
• A Case of Acromegaly With Progressed Diabetic Retinopathy and Sarcopenia Diagnosed Following the Onset of Severe Hypoglycemia
• A review of complex hormone regulation in thyroid cancer: novel insights beyond the hypothalamus-pituitary-thyroid axis
• A Review on Coexisting Giants: The Interplay Between Acromegaly and Diabetes Mellitus
• Acromegaly and COVID-19, lessons, and new opportunities
• Acromegaly Disease Control Maintained After Switching From Injected Somatostatin Receptor Ligands to Oral Paltusotine
• Acromegaly in humans and cats: Pathophysiological, clinical and management resemblances and differences
• Acromegaly in pregnancy - one step away from neurosurgical procedure
• Acromegaly management in the Nordic countries: A Delphi consensus survey
• Acromegaly screening in patients with hyperprolactinemia and pituitary adenoma
• Activated AMP-protein kinase (pAMPK) is overexpressed in human somatotroph pituitary adenomas
• Acute Interstitial Nephritis and Oxalate Nephropathy After Rapid Pasireotide Response in Treatment-resistant Acromegaly
• Addressing Acromegaly-Related Malocclusion With Surgery-First Orthognathic Surgery: A Clinical Case Report
• Advancement in perioperative management of pituitary adenomas-Current concepts and best practices
• Alteration in gut microbial characteristics of patients with acromegaly
• Androgen Receptor-Positive Penile Acrochordon: A Case Report
• Aortic root dilation in acromegaly
• Best practice and research, clinical endocrinology and metabolism preface to the special issue: Diagnosis and treatment of acromegaly acromegaly, a paradigmatic disease second part: Treatment
• Biliary Tract Disorders and Associated Acute Complications in Patients With Acromegaly: A Single-Center Study
• Blood Glucose Levels Moderate the Associations Between IGF-1 Levels and Choroidal Metrics in Patients With Diabetes With Acromegaly Without Diabetic Retinopathy
• Cardiac MRI in acromegaly: looking for a big heart
• Cardiovascular risk in patients with acromegaly vs. non-functioning pituitary adenoma following pituitary surgery: an active-comparator cohort study
• Cervicogenic-Like Headache as the First Symptom of Acromegaly
• Characteristics and treatment of a silent somatotroph tumor that had transformed to a functional type: a case report and literature review
• Clinical observation of 7 cases of functional pituitary neuroendocrine tumor treated by endoscopic transnasal selective resection of the cavernous sinus medial wall
• Clinical Pharmacology of Oral Octreotide Capsules for the Treatment of Acromegaly
• Clinically active pituitary tumors
• Concurrent Papillary Craniopharyngioma and Growth Hormone-Secreting Pituitary Adenoma: A Rare and Aggressive Collision Tumor
• Copeptin after pituitary surgery: is it worth measuring?
• Correction to: "Fertility in Acromegaly: A Single-Center Experience of Female Patients During Active Disease and After Disease Remission"
• Correction: Utility of copeptin in predicting non-pathological postoperative polyuria in patients affected by acromegaly undergoing pituitary neurosurgery
• Craniofacial impact of acromegaly: when muscle ma-sse-tter
• Cutis verticis gyrata in a patient with acromegaly: an unusual case and review of literature
• Diabetes mellitus in patients with acromegaly: pathophysiology, clinical challenges and management
• Diagnostic characteristics and management outcome in patients with acromegaly: A 15-year experience at a tertiary care hospital in Pakistan
• Diagnostic, therapeutic, and prognostic characteristics of patients with acromegaly according to tumor size at diagnosis
• Diaphragm reconstruction using a TachoSil patch as alternative to intrasellar packing for small focal diaphragm defects in pituitary surgery: a cohort study
• Differential gene expression and pathway analysis in growth hormone-secreting pituitary tumors according to granulation pattern
• Disrupted harmony of the skull skeleton: Middle ear resonance in acromegaly
• DXA-derived lumbar bone strain index corrected for kyphosis is associated with vertebral fractures and trabecular bone score in acromegaly
• Early postoperative growth hormone measurement as a predictive marker for acromegaly remission
• Effect of Cabergoline on weight and glucose metabolism in patients with acromegaly
• Effectiveness of Combined First-Line Medical Treatment in Acromegaly with Prolactin Co-secretion
• Effectiveness of combined first-line medical treatment in acromegaly with prolactin cosecretion
• Efficacy and safety of radiosurgery in acromegaly
• Excess endocrine growth hormone in acromegaly promotes the aggressiveness and metastasis of triple-negative breast cancer
• Expanded endoscopic endonasal approach for resection of residual parasellar growth hormone-secreting pituitary adenoma in a patient with kissing internal carotid arteries: Technical nuances
• Expert consensus on the diagnosis and treatment of obstructive sleep apnea in women
• Exploring potential influencing factors of inadherence to specialist aftercare and long-term medication in patients with acromegaly
• Germline AIP variants in sporadic young acromegaly and pituitary gigantism: clinical and genetic insights from a Han Chinese cohort
• GIP receptor antagonism eliminates paradoxical growth hormone secretion in some patients with acromegaly
• Glucose metabolism outcomes after pituitary surgery in patients with acromegaly
• Growth hormone increase by luteinizing hormone-releasing hormone reflects gonadotroph-related characteristics in acromegaly
• Growth hormone receptor antagonist pegvisomant and its role in the medical therapy of growth hormone excess
• IGF-I assay methods and biologic variability: evaluation of acromegaly treatment response
• Impact of medical therapy for hormone-secreting Pituitary tumors on bone
• Increased insulin-like growth factor 1 concentrations in a population of non-diabetic cats with overweight/obesity
• Insights from an Italian Delphi panel: exploring resistance to first-generation somatostatin receptor ligands and guiding second-line medical therapies in acromegaly management
• Insulin-Like Growth Factor 1 as a Pillar in Acromegaly: From Diagnosis to Long-Term Management
• Is diabetes with acromegaly for life?
• Long-term pasireotide-LAR treatment in the personalized therapy of patients with complex acromegaly: a collection of clinical experiences
• Long-term Pegvisomant Therapy of Acromegaly: Effects on Bone Density, Turnover and Microstructure Using HRpQCT
• Macroglossia in endocrine and metabolic disorders: current evidence, perspectives and challenges
• Management of Diabetes Mellitus in Acromegaly and Cushing's Disease with Focus on Pasireotide Therapy: A Narrative Review
• Medical treatment of acromegaly - When the tumor size matters: A narrative review
• Medical treatment of functional pituitary adenomas, trials and tribulations
• Obstructive Sleep Apnea Screening and Effects of Surgery in Acromegaly: A Prospective Study
• Oral Octreotide Capsules and Paltusotine in Management of Acromegaly
• Oral octreotide capsules for acromegaly treatment: application of clinical trial insights to real-world use
• Outcome of endoscopic transsphenoidal surgery for acromegaly: Comparison of using and not using the floor standing pneumatic powered endoscope-holder system
• Paltusotine: A Step Towards Precision Medicine in Acromegaly
• Pancreatic GHRHomas in Patients with or without Multiple Endocrine Neoplasia Type 1 (MEN 1) : An Analysis of 36 Reported Cases
• Paradoxical effect of dopamine-agonists on IGF-1 in patients with prolactinoma: the role of weight
• Personalized medicine in acromegaly: The ACROFAST study
• Pituitary Disorders
• Pituitary tumor centers of excellence (PTCOE): the next border of acromegaly treatment
• Predictors of Remission of Acromegaly following Surgical Treatment in Growth Hormone-Secreting Pituitary Adenoma
• Prospective, longitudinal study of cancer predictors and rates in a New York City cohort of 598 patients with acromegaly
• Quality of life in patients with acromegaly: a scoping review
• Rapid Resolution of Recalcitrant Headache With Pasireotide in an Adult Patient With Acromegaly
• Response to "Acromegaly: Overview and associated temporomandibular joint disorders"
• Risk of intracranial meningioma in patients with acromegaly: a systematic review
• Serum phosphate levels at diagnosis predict long-term risk for hypopituitarism in patients with acromegaly
• Standards of care for medical management of acromegaly in pituitary tumor centers of excellence (PTCOE)
• Structure and Function of Somatostatin and its Receptors in Endocrinology
• Suspected silent pituitary somatotroph neuroendocrine tumor associated with acromegaly-like bone disorders: a case report
• Temporal and masseter muscle evaluation by MRI provides information on muscle mass and quality in acromegaly patients
• The Association Between Oxidative Stress and Sperm Parameters in Patients with Acromegaly
• The comprehensive evaluation of oral and fecal microbiota in patients with acromegaly
• The Preoperative Paradoxical GH Response to Oral Glucose Load Predicts a low Risk of Recurrence in Acromegaly
• The Role of the GH Receptor Polymorphisms as a Prognostic Factor of Vertebral Fractures in Acromegalic Patients Resistant to First-generation SSAs and Treated with Pegvisomant or Pasireotide LAR
• The spectrum of cardiac abnormalities in patients with acromegaly: results from a case-control cardiac magnetic resonance study
• Three-Dimensional Speckle-Tracking Echocardiography-Derived Tricuspid Annular Properties in Acromegaly-Results from the MAGYAR-Path Study
• Time to first remission and survival in patients with acromegaly: Evidence from the UK Acromegaly Register Study (UKAR)
• Transcriptome-Derived Ligand-Receptor Interactome of Major PitNET Subgroups
• Treatment of acromegaly with the nonpeptide, highly selective somatostatin receptor type 2 agonist paltusotine
• Uncontrolled Acromegaly Resulting in the Need for Left Ventricular Assist Device as Bridge to Heart Transplant
• Unexplained massive pulmonary embolism in acromegaly patient: A case report
• Use of a Suction-Monopolar Stimulator for Continuous Neurophysiology Monitoring During Endonasal Resection of a Cavernous Sinus Schwannoma: 2-Dimensional Operative Video
• Utility of copeptin in predicting non-pathological postoperative polyuria in patients affected by acromegaly undergoing pituitary neurosurgery